Literature DB >> 19303038

A designer biomimetic vector with a chimeric architecture for targeted gene transfer.

Yuhua Wang1, Sriramchandra Sastry Mangipudi, Brenda F Canine, Arash Hatefi.   

Abstract

Designer biomimetic vectors are genetically engineered biomacromolecules that are designed to mimic viral characteristipan> class="Chemical">cs in order to overcome the cellular barriers associated with the targeted gene transfer. The vector in this study was genetically engineered to contain at precise locations: a) four tandem repeating units of N-terminal domain of histone H2A to condense DNA into stable nanosize particles suitable for cellular uptake, b) a model targeting motif to target HER2 and enhance internalization of nanoparticles, and c) a pH-responsive synthetic fusogenic peptide to disrupt endosome membranes and promote escape of the nanoparticles into the cytosol. The results demonstrate that a fully functional, multi-domain, designer vector can be engineered to target cells with high specificity, overcome the biological barriers associated with targeted gene transfer, and mediate efficient gene transfer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19303038      PMCID: PMC2925643          DOI: 10.1016/j.jconrel.2009.03.005

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  24 in total

1.  Comparative gene transfer efficiency of low molecular weight polylysine DNA-condensing peptides.

Authors:  D L McKenzie; W T Collard; K G Rice
Journal:  J Pept Res       Date:  1999-10

2.  Low molecular weight disulfide cross-linking peptides as nonviral gene delivery carriers.

Authors:  D L McKenzie; E Smiley; K Y Kwok; K G Rice
Journal:  Bioconjug Chem       Date:  2000 Nov-Dec       Impact factor: 4.774

3.  CL22 - a novel cationic peptide for efficient transfection of mammalian cells.

Authors:  A M Haines; A S Irvine; A Mountain; J Charlesworth; N A Farrow; R D Husain; H Hyde; H Ketteringham; R H McDermott; A F Mulcahy; T L Mustoe; S C Reid; M Rouquette; J C Shaw; D R Thatcher; J H Welsh; D E Williams; W Zauner; R O Phillips
Journal:  Gene Ther       Date:  2001-01       Impact factor: 5.250

4.  Structure and function correlation in histone H2A peptide-mediated gene transfer.

Authors:  Danuta Balicki; Christopher D Putnam; Puthupparampil V Scaria; Ernest Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

Review 5.  NLS bioconjugates for targeting therapeutic genes to the nucleus.

Authors:  Virginie Escriou; Marie Carrière; Daniel Scherman; Pierre Wils
Journal:  Adv Drug Deliv Rev       Date:  2003-02-10       Impact factor: 15.470

6.  Efficient active transport of gene nanocarriers to the cell nucleus.

Authors:  Junghae Suh; Denis Wirtz; Justin Hanes
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-18       Impact factor: 11.205

7.  Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis.

Authors:  Joanna Rejman; Volker Oberle; Inge S Zuhorn; Dick Hoekstra
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

8.  Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer.

Authors:  D Li; L Duan; P Freimuth; B W O'Malley
Journal:  Clin Cancer Res       Date:  1999-12       Impact factor: 12.531

9.  Multifunctional nanorods for gene delivery.

Authors:  Aliasger K Salem; Peter C Searson; Kam W Leong
Journal:  Nat Mater       Date:  2003-09-14       Impact factor: 43.841

10.  Real-time intracellular transport of gene nanocarriers studied by multiple particle tracking.

Authors:  Junghae Suh; Denis Wirtz; Justin Hanes
Journal:  Biotechnol Prog       Date:  2004 Mar-Apr
View more
  15 in total

1.  Development of targeted recombinant polymers that can deliver siRNA to the cytoplasm and plasmid DNA to the cell nucleus.

Authors:  Brenda F Canine; Yuhua Wang; Wenyun Ouyang; Arash Hatefi
Journal:  J Control Release       Date:  2010-12-28       Impact factor: 9.776

2.  Production of low-expressing recombinant cationic biopolymers with high purity.

Authors:  Xuguang Chen; Alireza Nomani; Niket Patel; Arash Hatefi
Journal:  Protein Expr Purif       Date:  2017-03-16       Impact factor: 1.650

3.  Development of a Recombinant Multifunctional Biomacromolecule for Targeted Gene Transfer to Prostate Cancer Cells.

Authors:  Arash Hatefi; Zahra Karjoo; Alireza Nomani
Journal:  Biomacromolecules       Date:  2017-08-24       Impact factor: 6.988

4.  Cathepsin B-sensitive polymers for compartment-specific degradation and nucleic acid release.

Authors:  David S H Chu; Russell N Johnson; Suzie H Pun
Journal:  J Control Release       Date:  2011-10-20       Impact factor: 9.776

Review 5.  Functional peptides for siRNA delivery.

Authors:  Wanyi Tai; Xiaohu Gao
Journal:  Adv Drug Deliv Rev       Date:  2016-08-13       Impact factor: 15.470

Review 6.  Multivalent protein polymers with controlled chemical and physical properties.

Authors:  Ayben Top; Kristi L Kiick
Journal:  Adv Drug Deliv Rev       Date:  2010-06-01       Impact factor: 15.470

7.  Frontiers in Suicide Gene Therapy of Cancer.

Authors:  Marek Malecki
Journal:  J Genet Syndr Gene Ther       Date:  2012-10-22

8.  Biosynthesis and characterization of a novel genetically engineered polymer for targeted gene transfer to cancer cells.

Authors:  Brenda F Canine; Yuhua Wang; Arash Hatefi
Journal:  J Control Release       Date:  2009-04-18       Impact factor: 9.776

9.  Efficient protection and transfection of small interfering RNA by cationic shell-crosslinked knedel-like nanoparticles.

Authors:  Yuefei Shen; Huafeng Fang; Ke Zhang; Ritu Shrestha; Karen L Wooley; John-Stephen A Taylor
Journal:  Nucleic Acid Ther       Date:  2013-04       Impact factor: 5.486

Review 10.  Bioengineering a non-genotoxic vector for genetic modification of mesenchymal stem cells.

Authors:  Xuguang Chen; Alireza Nomani; Niket Patel; Faranak S Nouri; Arash Hatefi
Journal:  Biomaterials       Date:  2017-10-20       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.